NO994233L - Sterol-estere i faste, tabletterte doseringsformer - Google Patents

Sterol-estere i faste, tabletterte doseringsformer

Info

Publication number
NO994233L
NO994233L NO994233A NO994233A NO994233L NO 994233 L NO994233 L NO 994233L NO 994233 A NO994233 A NO 994233A NO 994233 A NO994233 A NO 994233A NO 994233 L NO994233 L NO 994233L
Authority
NO
Norway
Prior art keywords
solid
dosage forms
sterol esters
tableted dosage
tableted
Prior art date
Application number
NO994233A
Other languages
English (en)
Other versions
NO994233D0 (no
Inventor
Richard D Bruce
John D Higgins
Stephen A Martellucci
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of NO994233D0 publication Critical patent/NO994233D0/no
Publication of NO994233L publication Critical patent/NO994233L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO994233A 1998-09-02 1999-09-01 Sterol-estere i faste, tabletterte doseringsformer NO994233L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/145,528 US6376481B2 (en) 1998-09-02 1998-09-02 Sterol esters in tableted solid dosage forms

Publications (2)

Publication Number Publication Date
NO994233D0 NO994233D0 (no) 1999-09-01
NO994233L true NO994233L (no) 2000-03-03

Family

ID=22513518

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994233A NO994233L (no) 1998-09-02 1999-09-01 Sterol-estere i faste, tabletterte doseringsformer

Country Status (12)

Country Link
US (1) US6376481B2 (no)
EP (1) EP0985411B1 (no)
JP (1) JP2000103737A (no)
AT (1) ATE282405T1 (no)
AU (1) AU764513B2 (no)
BR (1) BR9903992A (no)
CA (1) CA2281251C (no)
DE (1) DE69921919T2 (no)
DK (1) DK0985411T3 (no)
NO (1) NO994233L (no)
NZ (1) NZ337574A (no)
PT (1) PT985411E (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
WO2000038655A1 (en) * 1998-12-23 2000-07-06 Alza Corporation Dosage forms comprising porous particles
KR20020026053A (ko) * 2000-09-30 2002-04-06 노승권 음료용 식물성 스테롤의 분산방법 및 이를 함유하는 음료
EP1404302B1 (en) * 2001-06-22 2010-11-03 Pfizer Products Inc. Pharmaceutical compositions comprising adsorbates of amorphous drug
EP1469832B2 (en) * 2002-02-01 2016-10-26 Bend Research, Inc. Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
CN1325056C (zh) * 2002-05-20 2007-07-11 大塚制药株式会社 用于改善黑斑病的组合物以及用于减轻肌肤黯淡的组合物
KR101153459B1 (ko) 2002-06-12 2012-06-07 더 코카콜라 컴파니 식물성 스테롤을 함유하는 음료
US7306819B2 (en) 2002-06-12 2007-12-11 The Coca-Cola Company Beverages containing plant sterols
US6946151B2 (en) * 2002-11-12 2005-09-20 Ayurvedic-Life International, Llc Therapeutic compositions
US6949261B2 (en) 2002-11-12 2005-09-27 Ayurvedic-Life International, Llc Compositions for diabetes treatment and prophylaxis
WO2005011635A2 (en) 2003-08-04 2005-02-10 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
MXPA06005593A (es) * 2003-11-20 2007-02-12 Zomanex Llc Metodos y formulaciones para el tratamiento de condiciones medicas relacionadas con la dihidrotestosterona elevada.
US8968768B2 (en) * 2004-03-29 2015-03-03 Wyeth Llc Phytosterol nutritional supplements
DK1732605T3 (da) * 2004-03-29 2019-06-11 Wyeth Llc Multi-vitamin- og mineral-kosttilskud
DE102005022953A1 (de) * 2005-05-19 2006-11-23 Chemische Fabrik Budenheim Kg Nahrungsergänzungsmittel
ATE530178T1 (de) 2007-05-23 2011-11-15 Amcol International Corp Mit cholesterin interagierende phyllosilikate und verfahren zur reduktion von hypercholesterinämie bei einem säuger
EP2257173B1 (en) * 2008-02-27 2014-07-30 Amcol International Corporation Protonated hydrogen ion-exchanged layered phyllosilicate material for use in treating atherosclerosis
US8039025B1 (en) 2010-10-15 2011-10-18 Life Plus, LLC Methods and dosage forms for the treatment of human cancers
GB201502077D0 (en) * 2015-02-09 2015-03-25 Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd Improved hme technology

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB284814A (en) 1926-11-29 1928-02-09 Leonard Miller Improvements in or relating to hoists or derricks
US3004043A (en) 1959-10-09 1961-10-10 Eastman Kodak Co Water-soluble vegetable oil sterol derivatives
US3203862A (en) 1960-03-11 1965-08-31 Jones John Harris Oral anti-hypercholesterol composition
US3495011A (en) 1968-10-28 1970-02-10 Unimed Inc Reduction of blood level cholesterol
US3865939A (en) * 1973-02-23 1975-02-11 Procter & Gamble Edible oils having hypocholesterolemic properties
US3881005A (en) 1973-08-13 1975-04-29 Lilly Co Eli Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof
US4160850A (en) 1975-08-25 1979-07-10 General Mills, Inc. Shelf-stable mix for a spreadable butter-substitute
US4195084A (en) 1977-01-07 1980-03-25 Eli Lilly And Company Taste-stable aqueous pharmaceutical suspension of tall oil sitosterols and a method for the preparation thereof
GB1598638A (en) 1978-04-18 1981-09-23 Gen Mills Inc Butter-substitute products comprising an emulsifier water oil and hard fat and compositions and processes for the production thereof
US4238520A (en) 1979-06-28 1980-12-09 Scm Corporation Low-fat comestible spread substitutes
US4705875A (en) 1984-06-13 1987-11-10 Mitchell David C Substituted fructose compounds and vitamin supplements and methods for making same
US4588717A (en) 1984-06-13 1986-05-13 David C. Mitchell Medical Research Institute Compounds and vitamin supplements and methods for making same
US4824672A (en) 1986-06-06 1989-04-25 Hauser-Kuhrts, Inc. Method and composition for reducing serum cholesterol
US4883788A (en) 1986-06-06 1989-11-28 Hauser-Kuhrts, Inc. Method and composition for reducing serum cholesterol
GB8623557D0 (en) * 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
US5082684A (en) 1990-02-05 1992-01-21 Pfizer Inc. Low-calorie fat substitute
US5306515A (en) 1990-04-26 1994-04-26 The Procter & Gamble Company Reduced calorie pourable shortening, cooking oils, salad oils or like compositions
US5306514A (en) 1990-04-26 1994-04-26 The Procter & Gamble Company Solid, nondigestible, fat-like compounds and food compositions containing same
US5514398A (en) 1990-11-05 1996-05-07 Amano Pharmaceutical Co., Ltd. Food additive and use thereof
HU217625B (hu) 1991-05-03 2000-03-28 Raisio Benecol Ltd. Új eljárás szérum-koleszterinszint csökkentését szolgáló béta-szitosztanin-zsírsav-észterek és észterkeverékek, valamint ezeket tartalmazó élelmiszerek előállítására
US5338563A (en) 1992-05-01 1994-08-16 Nabisco, Inc. Process for the preparation of a spatter-resistant low-fat spread
GB9220268D0 (en) 1992-09-25 1992-11-11 Unilever Plc Cosmetic composition
US5326825A (en) 1992-11-27 1994-07-05 Naesman Jan H Process for the preparation of a graft copolymer bound catalyst
WO1995000158A1 (en) 1993-06-25 1995-01-05 Bio-Sphere Technology Dietary supplement incorporating beta-sitosterol and pectin
US5472728A (en) 1994-04-22 1995-12-05 Kraft Foods, Inc. Edible fat-containing margarine type products and process for preparing same
GB9410867D0 (en) * 1994-05-31 1994-07-20 Ucb Sa Radiation curable compositions
US5770254A (en) 1994-10-21 1998-06-23 Healthy Foods Solutions, Inc. Reduced-fat compositions and methods for preparing and using same
EP0960567B1 (en) 1995-06-01 2005-10-05 Unilever N.V. Fat based food products
DE69623904T2 (de) 1995-11-02 2003-05-15 Lipidia Holding S A Stabile essbare Ölzusammensetzung
US6139872A (en) 1996-08-14 2000-10-31 Henkel Corporation Method of producing a vitamin product
US6025010A (en) 1997-11-21 2000-02-15 Lipton, Division Of Conopco, Inc. Multifunctional spread
IN185730B (no) * 1998-02-19 2001-04-14 Mcneil Ppc Inc
US6110502A (en) * 1998-02-19 2000-08-29 Mcneil-Ppc, Inc. Method for producing water dispersible sterol formulations
US6025348A (en) 1998-04-30 2000-02-15 Kao Corporation Oil and fat composition containing phytosterol
SE512958C2 (sv) 1998-04-30 2000-06-12 Triple Crown Ab Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning
US6087353A (en) * 1998-05-15 2000-07-11 Forbes Medi-Tech Inc. Phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like
US5932562A (en) * 1998-05-26 1999-08-03 Washington University Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same
CA2334449A1 (en) 1998-06-05 1999-12-16 Radka K. Milanova Compositions comprising phytosterol, phytostanol or mixtures of both having enhanced solubility and dispersability and incorporation thereof into foods, beverages, pharmaceuticals, nutraceuticals and the like
US6242001B1 (en) * 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds

Also Published As

Publication number Publication date
EP0985411B1 (en) 2004-11-17
DE69921919T2 (de) 2005-11-24
CA2281251C (en) 2008-12-30
DE69921919D1 (de) 2004-12-23
AU764513B2 (en) 2003-08-21
EP0985411A1 (en) 2000-03-15
DK0985411T3 (da) 2005-03-14
CA2281251A1 (en) 2000-03-02
ATE282405T1 (de) 2004-12-15
NO994233D0 (no) 1999-09-01
US6376481B2 (en) 2002-04-23
NZ337574A (en) 2000-11-24
JP2000103737A (ja) 2000-04-11
BR9903992A (pt) 2000-09-19
AU4585299A (en) 2000-03-16
PT985411E (pt) 2005-02-28
US20010009677A1 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
NO994233D0 (no) Sterol-estere i faste, tabletterte doseringsformer
TR199701018T1 (xx) Oral 2-metil-tieno-benzodiazepin form�lasyonu.
DK1075191T4 (da) Phytosterolsammensætninger
AU3235395A (en) Integrated process for the manufacture of lactide
ATE385409T1 (de) Komponenten und verfahren für die verbesserte herstellung von abdrücken
HUP9900457A3 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
WO2003028576A3 (en) Method and apparatus for dental implants
TR199600792A2 (tr) Dihaloazolopirimidinlerin hazirlanmasina yönelik proses.
ATE364620T1 (de) Amphotere sterole und deren verwendung
HK1060120A1 (en) Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments constaining said compounds, and the use thereof for treating disorders of the lipid metabolism
IL140419A0 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
WO2001045678A3 (de) Arzneimittel, verfahren zu dessen herstellung und dessen verwendung
ES2168766T3 (es) Preparacion farmaceutica que incluye el propeptido vwf.
UA6044A1 (uk) Спосіб одержання метіленових похідних андроста-1,4 -діен-3,17-діона
NO994822L (no) Immunotolerant protrombinkomplekspreparat
ATE193971T1 (de) Implantat
DE60015508T2 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
DE59902109D1 (de) Gaskarburierungsverfahren zur Herstellung von reinem WC-Pulver
EA199800102A1 (ru) Получение производных бициклогексана
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
HUP0302818A3 (en) A process for the preparation of 2,2-dimethyl-5-(4-chlorobenzyl)cyclopentanone and an intermediate useful therefor
NO990450D0 (no) Behandling av sinnslidelser
RS20050366A (en) A method for preparing indan-1,3- dicarboxylic acid
TW200514775A (en) Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof
DE69802171D1 (de) Verfahren zur herstellung von 10,11-dihydro-5h-dibenzo(a,d)cyclohept-5-enen und ihren derivaten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application